Skip to main content

J&J Settles Washington AG’s Pelvic Mesh Suit For $9.9M

J&J Settles Washington AG’s Pelvic Mesh Suit For $9.9M

J&J Settles Washington AG’s Pelvic Mesh Suit For $9.9M

Introduction

On the eve of trial, Johnson & Johnson's subsidiary Ethicon Inc. agreed to pay $9.9 million to settle the first lawsuit brought by Washington Attorney General Bob Ferguson accusing the company of downplaying the risks of its pelvic mesh products.

The New Jersey-based company was sued by the Attorney General in 2016, saying its Ethicon Inc. breached the state’s Consumer Protection Act by failing to warn patients and doctors about the dangers and irreversible complications of its defective products. According to claims filed by thousands of women, the surgical mesh intended to render extra support to damaged or weakened tissue caused urinary dysfunction, constipation, sexual problems, and severe pain. The defendants who were supposed to face the trial in King County Superior Court on Monday, April 22, did not admit wrongdoing. According to Ferguson’s office, about 14,000 Washington women were implanted with the company's pelvic mesh, and the settlement amount will be helpful for them. The Attorney General will declare a formal claims process for the affected women soon.

Ethicon pelvic mesh lawsuits are consolidated as a part of multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) before U.S. District Judge Joseph R. Goodwin in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!